Product Information
MINOCYCLINE ER 55 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $2.9137 per EA under NDC 67877043630. Its NADAC has been published 113 times since Apr 17, 2024.
FDA first approved this application on Sep 28, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Minocycline Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
55 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877043630
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
6/18/2025
Active Ingredients
MINOCYCLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204453FDA Approved
9/28/2016
TE Code
AB
On Market Since
12/23/2019
Pharmacological Classes
Price Statistics
The NADAC for MINOCYCLINE ER 55 MG TABLET has been published 113 times since Apr 17, 2024, and over the history we have for it it has risen 3.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.9137 per EA |
|---|---|
| All-time high | $2.9358 (Feb 12, 2025) |
| All-time low | $2.2060 (Sep 18, 2024) |
| 52-week high | $2.9137 |
| 52-week low | $2.9137 |
| Median price | $2.8730 |
| Average price | $2.7494 |
| Largest weekly change | +18.2% (Nov 20, 2024) |
| Weeks tracked | 113 |
| Tracking since | Apr 17, 2024 |
1W
N/A
1M
N/A
3M
0.0%
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
+3.3%
Last surveyed Jun 10, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MINOCYCLINE ER 55 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MINOCYCLINE ER 55 MG TABLET, manufactured by Ascend Laboratories, LLC, is $2.9137 per EA (NDC 67877043630), effective Jun 10, 2026.
How has the price of MINOCYCLINE ER 55 MG TABLET changed over time?
Over the history we have for it, the NADAC for MINOCYCLINE ER 55 MG TABLET has risen 3.3%. It has been tracked across 113 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for MINOCYCLINE ER 55 MG TABLET?
Since Apr 17, 2024, the NADAC for MINOCYCLINE ER 55 MG TABLET has ranged from a low of $2.2060 (Sep 18, 2024) to a high of $2.9358 (Feb 12, 2025), with a median of $2.8730 per EA.
Are there cheaper alternatives to MINOCYCLINE ER 55 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MINOCYCLINE ER 55 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MINOCYCLINE ER 55 MG TABLET?
MINOCYCLINE ER 55 MG TABLET (NDC 67877043630) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.